KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $205.3 million.

  • Novavax's Non-Current Assets fell 66.28% to $205.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.3 million, marking a year-over-year decrease of 66.28%. This contributed to the annual value of $431.5 million for FY2024, which is 33.98% down from last year.
  • As of Q3 2025, Novavax's Non-Current Assets stood at $205.3 million, which was down 50.77% from $417.0 million recorded in Q2 2025.
  • Novavax's Non-Current Assets' 5-year high stood at $653.6 million during Q4 2023, with a 5-year trough of $205.3 million in Q3 2025.
  • Its 3-year average for Non-Current Assets is $523.9 million, with a median of $571.7 million in 2023.
  • In the last 5 years, Novavax's Non-Current Assets spiked by 396.43% in 2021 and then crashed by 66.28% in 2025.
  • Quarterly analysis of 5 years shows Novavax's Non-Current Assets stood at $421.6 million in 2021, then surged by 31.70% to $555.3 million in 2022, then increased by 17.71% to $653.6 million in 2023, then tumbled by 33.98% to $431.5 million in 2024, then crashed by 66.28% to $205.3 million in 2025.
  • Its last three reported values are $205.3 million in Q3 2025, $417.0 million for Q2 2025, and $425.0 million during Q1 2025.